Christopher Gregg in Hamburg
The Canadian scientist Dr. Christopher Gregg, Postdoctoral Fellow at Harvard University and 2010 winner of the Eppendorf & Science Prize for Neurobiology, visited Eppendorf headquarters in Hamburg in June of 2011.
(firmenpresse) - On this occasion Dr. Gregg gave a talk about his ground-breaking work on maternal and paternal gene expression in the brain. His research focuses on genes that alter their expression in the brains of offspring according to whether they were inherited from the father versus the mother. As a reminder of his visit to Hamburg Dr. Gregg was presented with Eppendorf’s new Research® plus pipette.
This international US$ 25,000 Eppendorf and Science Prize for Neurobiology is awarded jointly by Eppendorf and the journal Science. All young scientists who are 35 years of age or younger and who have made outstanding contributions to neurobiological research are invited to apply. The 2011 winner of the Prize will be announced in the autumn. The next deadline for applications is June 15, 2012. For more information visit www.eppendorf.com/prize.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Eppendorf is a biotech company which develops, produces and distributes systems for use in all spheres of life science. The company's broad range of high quality products and systems is used by researchers worldwide to efficiently carry out their work.
The product range includes pipettes, dispensers and centrifuges as well as consumables such as micro test tubes and pipette tips. In addition to this, Eppendorf provides instruments and systems for automated liquid handling. Even a complete range of devices for DNA amplification for standard PCR or real-time PCR as well as systems for cell manipulation and electroporation are available. New Brunswick Scientific, Edison, USA, stands for expertise and top products within the Eppendorf Group in the field of cell growth, detection and storage.
Eppendorf products are designed for academic and commercial research facilities, but also for industrial companies in the field of biotechnology and in other sectors using biotech research processes. Innovative research approaches will call for miniature applications with an increased sample throughput for future diagnostics and therapy. This implies a trend towards automation and a level of reproducibility for which the company's high level of technology and expertise will be sought after on the market.
Eppendorf is represented in all important markets worldwide. Although the company is placing main emphasis on North America as the regional market, Asia has a high potential with dynamic rates of growth.
Eppendorf was founded in Hamburg in 1945 and has more than 2500 employees worldwide. The company has subsidiaries in 18 countries and is represented in many other markets by distributors.
Eppendorf AG
Bettina Doerler
public relations officer
doerler.b(at)eppendorf.de
+49 40 538 01-640
Datum: 16.06.2011 - 16:13 Uhr
Sprache: Deutsch
News-ID 30589
Anzahl Zeichen: 0
contact information:
Kategorie:
Research & Development
Typ of Press Release: Unternehmensinformation
type of sending: Veröffentlichung
Date of sending: 16.06.2011
Diese Pressemitteilung wurde bisher 468 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Christopher Gregg in Hamburg"
steht unter der journalistisch-redaktionellen Verantwortung von
Eppendorf AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
